A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer
Authors:
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 391 (2) , 111817
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81072205)
- National Basic Research Program of China (2010CB529401)
This publication has 35 references indexed in Scilit:
- Sox2 maintains self renewal of tumor-initiating cells in osteosarcomasOncogene, 2011
- Deadly Teamwork: Neural Cancer Stem Cells and the Tumor MicroenvironmentCell Stem Cell, 2011
- p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2Journal of Experimental Medicine, 2011
- p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAsNature Cell Biology, 2011
- miR-200a Regulates Epithelial-Mesenchymal to Stem-like Transition via ZEB2 and β-Catenin SignalingJournal of Biological Chemistry, 2010
- Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem CellsMolecular Cell, 2010
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene, 2010
- p21 CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivoProceedings of the National Academy of Sciences, 2009
- Cancer stem cells: mirage or reality?Nature Medicine, 2009
- Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenanceProceedings of the National Academy of Sciences, 2007